Subscribe To
fibrogen (fgen) fails to meet goals in dmd study, stock down 23%
fibrogen (FGEN) falls 22.7% as its late-stage study of pamrevlumab for the treatment of ambulatory pati...
August 30, 2023, 12:46 pm
fibrogen stock plummets as muscular dystrophy drug trial fails
fibrogen Inc (NASDAQ:FGEN) plummeted some 27% lower in Wednesday's early deals after revealing that its...
August 30, 2023, 9:39 am
fibrogen shares fall after failure in late-stage study of duchenne muscular dystrophy treatment
Shares of fibrogen Inc. FGEN, +3.23% fell 23% premarket on Wednesday after the company said its investi...
August 30, 2023, 7:55 am
fibrogen announces topline results from lelantos-2, a phase 3 clinical study of pamrevlumab in ambulatory duchenne muscular dystrophy
– Study did not meet the primary endpoint – – Pamrevlumab was generally safe and well tolerated – SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE...
August 29, 2023, 8:15 pm
Down -46.88% in 4 weeks, here's why fibrogen (fgen) looks ripe for a turnaround
The heavy selling pressure might have exhausted for fibrogen (FGEN) as it is technically in oversold te...
August 16, 2023, 10:59 am
fibrogen, inc. (fgen) q2 2023 earnings call transcript
fibrogen, Inc. (NASDAQ:FGEN ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Partic...
August 7, 2023, 10:10 pm
fibrogen (fgen) q2 earnings: taking a look at key metrics versus estimates
The headline numbers for fibrogen (FGEN) give insight into how the company performed in the quarter end...
August 7, 2023, 9:09 pm
fibrogen (fgen) reports q2 loss, tops revenue estimates
fibrogen (FGEN) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate o...
August 7, 2023, 6:54 pm
Down -83.78% in 4 weeks, here's why fibrogen (fgen) looks ripe for a turnaround
The heavy selling pressure might have exhausted for fibrogen (FGEN) as it is technically in oversold te...
July 11, 2023, 11:03 am
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of fibrogen, inc. – fgen
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of f...
July 1, 2023, 10:59 pm
Down 80% in 1 day, is there any hope for fibrogen stock?
fibrogen's lead candidate whiffed twice in June. It has a significant chance of reporting more unfavora...
July 1, 2023, 8:46 am
fibrogen (fgen) plunges on failure of late-stage ipf study
fibrogen (FGEN) plummets on yet another pipeline setback. The phase III study, ZEPHYRUS-1, evaluating t...
June 27, 2023, 2:18 pm
fibrogen's unsteady course: assessing fallout from ipf failure and the road ahead
fibrogen stock has dropped significantly after the failure of its Zephyrus I trial for IPF treatment, l...
June 26, 2023, 3:26 pm
Why is fibrogen (fgen) stock down 81% today?
fibrogen (NASDAQ: FGEN ) stock is heading lower on Monday after the company's Phase 3 clinical trial fa...
June 26, 2023, 10:09 am
fibrogen (fgen) pamrevlumab fails dmd study, stock down 8%
fibrogen???s (FGEN) phase III study, evaluating pamrevlumab as a combination therapy in certain DMD pat...
June 8, 2023, 2:08 pm
Biotech stock falls on late-stage study
fibrogen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing re...
June 7, 2023, 10:29 am
fibrogen shares slide after duchenne muscular dystrophy treatment falls short in trial
Shares of fibrogen Inc. FGEN, -2.50% were down 5.6% premarket on Wednesday after the company announced ...
June 7, 2023, 8:08 am
fibrogen's neuromuscular disorder drug fails in late-stage study
fibrogen Inc said on Wednesday its drug to treat a type of neuromuscular disorder failed to meet the ma...
June 7, 2023, 7:38 am
fibrogen: several pamrevlumab data releases could change scope of biotech
fibrogen, Inc. results from the phase 3 LELANTOS-1 study, using pamrevlumab for the treatment of patien...
June 5, 2023, 3:27 pm
fibrogen, inc. (fgen) q1 2023 earnings call transcript
fibrogen, Inc. (NASDAQ:FGEN ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participa...
May 8, 2023, 11:14 pm